Aktis Pharma India Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 03-07-2024
- Paid Up Capital ₹ 3.00 M
as on 03-07-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 20.91%
(FY 2020)
- Profit 48.48%
(FY 2020)
- Ebitda 45.86%
(FY 2020)
- Net Worth 17.10%
(FY 2020)
- Total Assets 2.85%
(FY 2020)
About Aktis Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chintharlapalli Reddy, Ram Gabbireddy, Prashanth Chikkulapally, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TG2015PTC099593
- Company No.
099593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aktis Pharma India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayana Nussam  | Director | 03-Jul-2015 | Current |
Chintharlapalli Reddy  | Director | 03-Jul-2015 | Current |
| Ram Gabbireddy | Director | 03-Jul-2015 | Current |
| Prashanth Chikkulapally | Director | 03-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Aktis Pharma India.
Aktis Pharma India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.91% increase. The company also saw a substantial improvement in profitability, with a 48.48% increase in profit. The company's net worth Soared by an impressive increase of 17.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aktis Pharma India?
In 2020, Aktis Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aktis Pharma India?
Unlock and access historical data on people associated with Aktis Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Feb 09, 2016, Aktis Pharma India has raised a total of ₹ 4 M, with the most recent deal valued at ₹ 2 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
